GRANTS The University of Gothenburg has received just over SEK 121 million from the Swedish Research Council’s large funding opportunity. A distinct improvement from last year, the announcement meant that Gothenburg once again obtained the second highest award of all universities that participated.
The SEK 121 million earmarked for the University of Gothenburg represented 15% of the total funds awarded for health and medical research. Last year’s figures was 13%.
The university regained its status as the second highest winner. At SEK 367 million, Karolinska Institutet received exactly three times as much. Uppsala University was third and Lund University was fourth.
”I am gratified by the improvement, but we shouldn’t be too smug about it,” says Olle Larkö, Dean of Sahlgrenska Academy. ”The results were approximately what he had anticipated.”
The largest grant went to Ingmar Skoog, Professor of Psychiatry at the Department of Neuroscience and Physiology and the Director of the AgeCap Center. He obtained a total of SEK 7.2 million to proceed with the H70 population studies that have been under way since 1971.
”I was thrilled by the announcement,” Professor Skoog says. ”It was a powerful confirmation that our research is heading in the right direction.”
The studies will include more sophisticated biological projects that incorporate MRIs of circulation, neural networks and microbleeding, etc., neurochemical analyses in collaboration with Kaj Blennow and Henrik Zetterberg, body composition and genetics.
”Now we will have the chance to explore the dynamics of Alzheimer’s many years before the first symptoms develop, as well as the biology of depression in the elderly,” Professor Skoog says. He also points out how important the interdisciplinary effort at AgeCap is.
”That kind of cooperation is essential if we are to make real breakthroughs in understanding widespread diseases. The chance to learn more about so many aspects of life – everything from neurochemical changes in the cerebrospinal fluid to the love lives of the elderly – is totally fascinating.”
This year’s health and medicine funding opportunity covered project grants for general research, young scientists and alternative laboratory experimental methods in accordance with the 3R principle, as well as grants to employ part-time researchers in a clinical setting.
Entire list
Keep in mind that only an announcement through your personal Prisma account is a guarantee that you have been awarded the grant.
Jan Boren
Lipid retention in liver and heart leads to cardiovascular disease and poorer cardiac function
SEK 6,000,000
Mats Brännström
Treatment of uterine factor infertility – uterus transplantation and bioengineered uterus
SEK 4,000,000
Emma Börgeson – Young scientists
Lipoxins: a new method of promoting metabolic health in obese patients
SEK 6,000,000
Hans Carlsten
Estrogen – immunomodulation for rheumatic disease and osteoporosis
SEK 2,100,000
Claes Dahlgren
Regulation of natural immunity and inflammation using receptor ligands that activate or inhibit neutrophilia function
SEK 2,100,000
Elias Eriksson
Selective serotonin uptake inhibitors: mysteries and controversies
SEK 6,000,000
Huamei Forsman
Function and base of formyl peptide receptors for development of anti-inflammatory drugs
SEK 2,100,000
Henrik Hagberg
Perinatal brain injury
SEK 4,000,000
Eva Haglind
Minimally invasive surgical technique for treating prostate cancer and perforated colon diverticulitis
SEK 2,100,000
Suchitra Holgersson
Native extracellular matrix as scaffolds for tissue engineering of the pancreas with human stem cells
SEK 2,100,000
Jonas Ivarsson
Improved care in the hybrid room
SEK 6,000,000
Bo Jacobsson
Genetic and epidemiological studies of length of pregnancy
SEK 4,000,000
John-Olov Jansson
Glucagon-like peptid-1 (GLP-1) reduces fat mass via the interleukin-6 (IL-6) and IL-1 immunomodulators in the brain – how and where?
SEK 4,000,000
Elisabet Jerlhag Holm – Young scientists
Involvement of gastrointestinal hormones in addictive disorders
SEK 6,000,000
Sverker Jern
Epigenetic regulation of vascular thromboprotective mechanisms – new treatment target
SEK 2,100,000
Gudmundur Johannsson
Biochemical markers for glucocorticoids
SEK 4,000,000
Malin Johansson – Young scientists
Formation of an effective mucous layer to protect against intestinal bacteria, studied at the molecular level
SEK 6,000,000
Göran Landberg – Alternative laboratory experimental methods in accordance with the 3R principle
3D bioprinted breast cancer matrices as a surrogate for laboratory experiments
SEK 2,100,000
Joakim Larsson
Role of antibiotics in the environment for development, selection and propagation of antibiotic resistance
SEK 2,100,000
Carel le Roux
Mechanisms of diabetic kidney disease improvement by means of Roux-en-Y gastric bypass surgery
SEK 2,100,000
Ulf Lerner
Influence of hormones and inflammatory mediators on bone metabolism Studies of cell cultures, mice and humans
SEK 4,000,000
Per Lindahl
Interaction between Zfp148 and p53 – a target for drugs to treat arteriosclerosis and cancer
SEK 4,000,000
Anders Lindahl
Stem cells and molecular signaling for cartilage regeneration, aging and disease
SEK 2,100,000
Lauren Lissner
EpiLife-Child: Family and intergenerational obesity
SEK 4,000,000
Philip Moons
Evaluation of a person-centered structured transition program for young people with long-term diseases as they enter adulthood STEPSTONES
SEK 6,000,000
Jonas Nilsson
DNA damage responses as a target for treating cancer
SEK 6,000,000
Stina Simonsson
Treatment of osteoarthritis with human induced pluripotent stem cells (iPSC) in 3D bioprinted nanocellulose structures
SEK 2,800,000
Ingmar Skoog
Psychological and cognitive health in relation to functioning and physical health in the elderly Impact of age, gender, birth cohort, genetic, psychological, social and neurobiological factors
SEK 7,200,000
Bo Söderpalm
Integrative preclinical and clinical studies of alcoholism
SEK 6,400,000
Changlian Zhu
Experimental and clinical studies of new treatment strategies in perinatal brain injuries
SEK 2,100,000
Lena Öhman
Bacterial and immunological indicators of disease progression and therapeutic response in patients with chronic inflammatory bowel disease
SEK 4,000,000
